Rankings
▼
Calendar
PLSE
Pulse Biosciences, Inc.
$1B
Q1 2020 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-0.57
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$32M
Total Liabilities
$10M
Stockholders' Equity
$22M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$167,000
+100.0%
Operating Income
-$12M
-$10M
-14.8%
Net Income
-$12M
-$10M
-17.8%
← FY 2020
All Quarters
Q2 2020 →
PLSE Q1 2020 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena